Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1988-11-01
1991-11-26
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 16, 530326, 530327, 530328, A61K 3702, C07K 706
Patent
active
050682229
ABSTRACT:
The invention relates to a polypeptide of formula I:
REFERENCES:
patent: 4332661 (1982-06-01), Ford et al.
patent: 4405778 (1983-09-01), Scartazzini et al.
patent: 4839344 (1989-06-01), Bowers et al.
patent: 4866160 (1989-09-01), Coy
patent: 4943561 (1990-07-01), Heimbrook et al.
Heimbrook et al., Minimal Ligand Analysis of Gastrin Releasing Peptide, 1988, pp. 7016-7019.
Coy et al., Probing Peptide Backbone Function in Bombesin, 1988, pp. 5056-5060.
Bioactivities, vol. 2, No. 1, Mar. 1988, "Highly Specific Bobesin Rerceptor Antagonist", See also Other New Produces from Bachem (Ibid).
Camble Roger
Cotton Ronald
Dutta Anand S.
Hayward Christopher F.
Davenport Avis
Imperial Chemical Industries plc
Lee Lester L.
LandOfFree
Bombesin antagonists with deletion of net-residue at the C-termi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bombesin antagonists with deletion of net-residue at the C-termi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bombesin antagonists with deletion of net-residue at the C-termi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2386001